[1] |
MA Yan, TIAN Gaopeng, SHI Xingwen, SUN Ting, XIE Jingjing, ZHEN Donghu.
Correlation between 25(OH)D and metabolically related fatty liver in T2DM population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1018-1026.
|
[2] |
WANG Donghui, JIANG Suwen, HU Airong, ZHU Bo, HE Zheyun, ZHANG Lukan, WANG Jialan, FAN Ying, LIN Ken .
Mulberry exerts antioxidant stress effect in rats with nonalcoholic fatty liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(6): 609-616.
|
[3] |
ZHU Li, WEI Bing, LIAO Shi'e, ZHANG Chao, ZHENG Xiaoyu, LIU Yajun.
Effects of single nucleotide polymorphism of drug metabolizing enzyme cytochrome P450 on the efficacy of inhaled cortisol hormone in asthmatic children
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 536-543.
|
[4] |
MA Shen, LIU Yushuo, TANG Hui, CHEN Wenbin, GAO Ling.
Pharmacokinetics and clinical significance of drugs for improving nonalcoholic fatty liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 908-918.
|
[5] |
ZHANG Liang, LIAO Yongqun, XIA Qinchuan, ZHOU Shitong, LI Xiaoli.
Ferroptosis regulatory signaling pathway and its research progress in related diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 227-234.
|
[6] |
WU Yi, FANG Fang, CHEN Ying, Fan Junwei.
Influence of donor and recipient CYP3A5 genotype on tacrolimus trough concentrations in the early stage after liver transplantation and its clinical significance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 631-639.
|
[7] |
SONG Ruzheng, PENG Ying, WANG Guangji, SUN Jianguo.
Commonly used quantitative proteomics research techniques and their application in the study of pathogenesis of liver-derived diseases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 570-578.
|
[8] |
WU Qiaoyu, YUAN Hong, LU Yao.
Evaluation of the effects of resveratrol on the activity human cytochrome P450 through combined probe method
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 426-432.
|
[9] |
WU Maofeng, LIU Chang, DAI Huihui, MAI Zhangfeng, HUANG Danli, MIAO Jingwei, LIU Lizhong, FANG Yi.
Preliminary association of individual different plasma pazopanib concentration with CYP3A4 gene polymorphism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(12): 1376-1380.
|
[10] |
WU Jiayuan, ZHENG Li, MO Juanfen, GUO Li, CAO Chenxi, BAO Yi.
Regulation of N-acetylcysteine on peripheral circulatory and hepatic myeloid-derived suppressor cells in non-alcoholic fatty liver disease mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 989-996.
|
[11] |
FANG Chuanchuan, NI Guantai, JIN Lan, LIU Ji, LIU Xiaoqing, QIAO Chun, LUO Yonghong.
Correlation between phosphorylation of PEA-15-Ser104 site and prognosis of epithelial ovarian cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 523-528.
|
[12] |
CHEN Xi, LING Jiawei, DING Jiaxin, JIANG Zhenzhou, ZHANG Luyong.
Advances in pathogenesis of nonalcoholic fatty liver disease caused by tamoxifen
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(6): 715-720.
|
[13] |
PENG Qiuju, YAN Huacheng, SHI Lei.
Advances in the relationship between cytochrome P450 SNP and susceptibility to coronary heart disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 477-480.
|
[14] |
ZHOU Hongping, YANG Xingxin, ZHUANG Rangxiao, SHAO Yidan, XI Jianjun, LIAO Li, REN Bailu, WANG Pingping, YU Shuying, SHI Tingting.
Effects of activated carbon N-acetylcysteine sustained-release microcapsule on miRNA of non-alcoholic fatty liver disease in young rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 263-270.
|
[15] |
ZHANG Peiyu, REN Jing, ZHI Wenqian, LIU Chengming, GAO Na.
Inhibition of CYP450 activity by honokiol and other four components of Chinese traditionalmedicine in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 922-926.
|